Abstract |
Quinoxaline derivatives are reported as antineoplastic agents against a variety of human cancer cell lines, with some compounds being submitted to clinical trials. In this work, we report the synthesis, characterization and cytotoxicity potential of a new series of quinoxalinyl- hydrazones. The most cytotoxic compound was (E)-2-[2-(2-pyridin-2-ylmethylene)hydrazinyl] quinoxaline (PJOV56) that presented a time-dependent effect against HCT-116 cells. After 48 h of incubation, PJOV56 was able to induce autophagy and apoptosis of HCT-116 cells, mediated by upregulation of Beclin 1, upregulation of LC3A/B II and activation of caspase 7. Apoptosis was induced along with G0/G1 cell cycle arrest at the highest concentration of PJOV56 (6.0 µM). Thus, PJOV56 showed a dose-dependent mode of action related to induction of autophagy and apoptosis in HCT-116 cells.
|
Authors | Sarah Sant'Anna Maranhão, Andrea Felinto Moura, Augusto César Aragão Oliveira, Daisy Jereissati Barbosa Lima, Francisco Washington Araújo Barros-Nepomuceno, Carlos Roberto Koscky Paier, Alessandra Campbell Pinheiro, Thais Cristina Mendonça Nogueira, Marcus Vinícius Nora de Souza, Claudia Pessoa |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 30
Issue 2
Pg. 126851
(01 15 2020)
ISSN: 1464-3405 [Electronic] England |
PMID | 31836446
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 Elsevier Ltd. All rights reserved. |
Chemical References |
|
Topics |
- Apoptosis
(drug effects)
- Autophagy
(drug effects)
- Colorectal Neoplasms
(drug therapy)
- Humans
- Hydrazones
(chemical synthesis, chemistry)
- Quinoxalines
(chemical synthesis, chemistry)
- Structure-Activity Relationship
|